APA (7th ed.) Citation

Singh, K., Foster, M. W., Violette, M. J., Corcoran, A. M., Hotchkiss, K. M., Railton, C. O., . . . Sampson, J. H. (2025). A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-21064-9

Chicago Style (17th ed.) Citation

Singh, Kirit, et al. "A Surgical Window of Opportunity Trial Evaluating the Effect of the PCSK9 Inhibitor Evolocumab on Tumoral MHC-I Expression and CD8+ Infiltration in Glioma." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-21064-9.

MLA (9th ed.) Citation

Singh, Kirit, et al. "A Surgical Window of Opportunity Trial Evaluating the Effect of the PCSK9 Inhibitor Evolocumab on Tumoral MHC-I Expression and CD8+ Infiltration in Glioma." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-21064-9.